Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR

High-risk (HR) human papillomavirus (HPV)-associated carcinogenesis is driven mainly by the overexpression of E7 and E6 oncoproteins following viral DNA integration and the concomitant loss of the E2 open reading frame (ORF). However, the integration of HR-HPV DNA is not systematically observed in c...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2013
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/28129
Acceso en línea:
https://doi.org/10.1128/JCM.01106-13
https://repository.urosario.edu.co/handle/10336/28129
Palabra clave:
DNA
Viral genetics
DNA
viral metabolism
DNA-binding proteins metabolism
Human papillomavirus 16 genetics
Oncogene proteins
Viral metabolism
Uterine cervical neoplasms virology
Female
Rights
License
Abierto (Texto Completo)
id EDOCUR2_fa6015ce1a2b01f205986e3dd9ad3db0
oai_identifier_str oai:repository.urosario.edu.co:10336/28129
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 6e1a7c81-97cf-47fb-a29f-4e4392d89b69-1a4278c90-7370-4b06-9c3a-33de7a315949-13d9819f5-d8f6-4bc8-ac5e-4c06c90187a5-13ee881f0-6cde-43c0-bd85-28f3b309c5c1-108603d15-9d1b-453d-9a5d-7eb2c3beff3a-19d9c0aa6-2b39-4348-b8a2-e91da3491535-14d70be68-aa48-4ae6-8b21-dfcbf238dd47-16558f37a-4c53-4550-8dd4-ec17f6d5760f-1413867c1-d4e9-4a0a-8b23-5ac3506e1b9e-19a59620b-af00-4c53-8b20-5b9f40f12666-16827786002020-08-19T14:45:58Z2020-08-19T14:45:58Z2013-09-20High-risk (HR) human papillomavirus (HPV)-associated carcinogenesis is driven mainly by the overexpression of E7 and E6 oncoproteins following viral DNA integration and the concomitant loss of the E2 open reading frame (ORF). However, the integration of HR-HPV DNA is not systematically observed in cervical cancers. The E2 protein acts as a transcription factor that governs viral oncogene expression. The methylation of CpGs in the E2-binding sites (E2BSs) in the viral long control region abrogates E2 binding, thus impairing the E2-mediated regulation of E7/E6 transcription. Here, high-resolution melting (HRM)–PCR was developed to quantitatively analyze the methylation statuses of E2BS1, E2BS2, and the specificity protein 1 (Sp1)-binding site in 119 HPV16-positive cervical smears. This is a rapid assay that is suitable for the analysis of cervical samples. The proportion of cancer samples with methylated E2BS1, E2BS2, and Sp1-binding site CpGs was 47%, whereas the vast majority of samples diagnosed as being within normal limits, low-grade squamous intraepithelial lesions (LSIL), or high-grade squamous intraepithelial lesions (HSIL) harbored unmethylated CpGs. Methylation levels varied widely, since some cancer samples harbored up to 60% of methylated HPV16 genomes. A pyrosequencing approach was used as a confirmation test and highlighted that quantitative measurement of methylation can be achieved by HRM-PCR. Its prognostic value deserves to be investigated alone or in association with other biomarkers. The reliability of this single-tube assay offers great opportunities for the investigation of HPV16 methylation in other HPV-related cancers, such as head and neck cancers, which are a major public health burden.application/pdfhttps://doi.org/10.1128/JCM.01106-13ISSN: 0095-1137EISSN: 1098-660Xhttps://repository.urosario.edu.co/handle/10336/28129engAmerican Society for MicrobiologyJournal of Clinical MicrobiologyJournal of Clinical Microbiology, ISSN: 0095-1137;EISSN: 1098-660X, Vol., No.(); pp. https://jcm.asm.org/content/jcm/51/10/3207.full.pdfAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2Journal of Clinical Microbiologyinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURDNAViral geneticsDNAviral metabolismDNA-binding proteins metabolismHuman papillomavirus 16 geneticsOncogene proteinsViral metabolismUterine cervical neoplasms virologyFemaleMethylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCRMetilación de sitios CpG del virus del papiloma humano tipo 16 en el sitio de unión 1 de E2 (E2BS1), E2BS2 y el sitio de unión de Sp1 en muestras de cáncer de cuello uterino, según lo determinado por análisis de fusión de alta resolución-PCRarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Jacquin, EliseBaraquin, AliceRamanah, RajeevCarcopino, XavierValmary-Degano, SéverineBravo, Ignacio G.de Sanjosé, SilviaRiethmuller, DidierMougin, ChristianePrétet, Jean-LucMorel, Adrien10336/28129oai:repository.urosario.edu.co:10336/281292021-06-03 00:51:12.474https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR
dc.title.TranslatedTitle.spa.fl_str_mv Metilación de sitios CpG del virus del papiloma humano tipo 16 en el sitio de unión 1 de E2 (E2BS1), E2BS2 y el sitio de unión de Sp1 en muestras de cáncer de cuello uterino, según lo determinado por análisis de fusión de alta resolución-PCR
title Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR
spellingShingle Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR
DNA
Viral genetics
DNA
viral metabolism
DNA-binding proteins metabolism
Human papillomavirus 16 genetics
Oncogene proteins
Viral metabolism
Uterine cervical neoplasms virology
Female
title_short Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR
title_full Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR
title_fullStr Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR
title_full_unstemmed Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR
title_sort Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR
dc.subject.keyword.spa.fl_str_mv DNA
Viral genetics
DNA
viral metabolism
DNA-binding proteins metabolism
Human papillomavirus 16 genetics
Oncogene proteins
Viral metabolism
Uterine cervical neoplasms virology
Female
topic DNA
Viral genetics
DNA
viral metabolism
DNA-binding proteins metabolism
Human papillomavirus 16 genetics
Oncogene proteins
Viral metabolism
Uterine cervical neoplasms virology
Female
description High-risk (HR) human papillomavirus (HPV)-associated carcinogenesis is driven mainly by the overexpression of E7 and E6 oncoproteins following viral DNA integration and the concomitant loss of the E2 open reading frame (ORF). However, the integration of HR-HPV DNA is not systematically observed in cervical cancers. The E2 protein acts as a transcription factor that governs viral oncogene expression. The methylation of CpGs in the E2-binding sites (E2BSs) in the viral long control region abrogates E2 binding, thus impairing the E2-mediated regulation of E7/E6 transcription. Here, high-resolution melting (HRM)–PCR was developed to quantitatively analyze the methylation statuses of E2BS1, E2BS2, and the specificity protein 1 (Sp1)-binding site in 119 HPV16-positive cervical smears. This is a rapid assay that is suitable for the analysis of cervical samples. The proportion of cancer samples with methylated E2BS1, E2BS2, and Sp1-binding site CpGs was 47%, whereas the vast majority of samples diagnosed as being within normal limits, low-grade squamous intraepithelial lesions (LSIL), or high-grade squamous intraepithelial lesions (HSIL) harbored unmethylated CpGs. Methylation levels varied widely, since some cancer samples harbored up to 60% of methylated HPV16 genomes. A pyrosequencing approach was used as a confirmation test and highlighted that quantitative measurement of methylation can be achieved by HRM-PCR. Its prognostic value deserves to be investigated alone or in association with other biomarkers. The reliability of this single-tube assay offers great opportunities for the investigation of HPV16 methylation in other HPV-related cancers, such as head and neck cancers, which are a major public health burden.
publishDate 2013
dc.date.created.spa.fl_str_mv 2013-09-20
dc.date.accessioned.none.fl_str_mv 2020-08-19T14:45:58Z
dc.date.available.none.fl_str_mv 2020-08-19T14:45:58Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1128/JCM.01106-13
dc.identifier.issn.none.fl_str_mv ISSN: 0095-1137
EISSN: 1098-660X
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/28129
url https://doi.org/10.1128/JCM.01106-13
https://repository.urosario.edu.co/handle/10336/28129
identifier_str_mv ISSN: 0095-1137
EISSN: 1098-660X
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationTitle.none.fl_str_mv Journal of Clinical Microbiology
dc.relation.ispartof.spa.fl_str_mv Journal of Clinical Microbiology, ISSN: 0095-1137;EISSN: 1098-660X, Vol., No.(); pp.
dc.relation.uri.spa.fl_str_mv https://jcm.asm.org/content/jcm/51/10/3207.full.pdf
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv American Society for Microbiology
dc.source.spa.fl_str_mv Journal of Clinical Microbiology
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390842389364736